(WSJ) – Western biotechs get new playbook with tighter controls to stay ahead of ultraefficient pharmaceutical pipeline overseas

For decades, young biotechs broadcast their science publicly to attract investment. Today, more are going dark to keep rivals, many of which are based in China, from replicating their research and doing studies in humans even faster than they can. (Read More)